Why We Invested in Resilient Lifescience — Preventing Opioid Overdose

ByMabel R. Acton

Jun 24, 2022 , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


Excited to announce our expenditure in Resilient Lifescience, which is taking on the opioid epidemic by building a wearable procedure to detect and immediately reverse overdoses. Tau Ventures is an AI-initial fund in Silicon Valley investing generally in seed and we once in a while take before or afterwards bets when we see huge guarantee. We are also investing in US / Canada but in outstanding circumstances will look at a deal outside the house. Resilient was founded in 2022 in Pittsburgh and impressed us with (1) a powerful will need, (2) building an execution-focused staff, and (3) their small business system.

1) The Want

The opioid disaster is really a tragedy that expenses $1T for every 12 months, touching all the 5Ps (payors, suppliers, sufferers, pharma, policymakers). Specifically, tin this article are now around 75,000 opioid overdose deaths for each 12 months in the US, and the the vast majority of them occur when nobody is close to to administer help (CDC, rand.org). We are in particular familiar with this house specified our expenditure in Marigold Health and fitness.


2) The Team

We imagined the cofounder’s backgrounds discuss for by themselves: https://www.linkedin.com/in/bradfordholden and https://www.linkedin.com/in/charlierproctor. CEO Brad was a Maritime for 4 years which include remaining a Platoon Commander in Afghanistan. CTO Charlie was an engineer at Google. They fulfilled at Infinitus, one more Tau portfolio organization, and their CEO invested individually and is the one who introed us.


3) Enterprise System

Components is tricky, as the bar for finding anything appropriate is much greater than in application, even a lot more so in health care. Manufacturing and distribution expenditures also create a really unique cost composition than software package ventures. We see a pathway for them to obtain far more information and fortify the analytics / AI piece of the solution. We respect the CEO’s approach to do purchaser discovery and subvert the typical archetype of medical gadgets becoming cash intense. We also subscribe to their thesis that getting in Pittsburgh will hold charges lower and let them obtain to wonderful talent, specially in engineering from Carnegie Mellon.

blankWe are honored and thrilled to be portion of Resilient’s journey, employing technology to solve a big problem. Extra at https://www.resilient.bio.

Originally published on “Info Driven Trader,” am content to syndicate on other platforms. I am the Managing Lover and Cofounder of Tau Ventures with 20 a long time in Silicon Valley throughout corporates, very own startup, and VC cash. These are purposely brief articles centered on simple insights (I get in touch with it gldr — very good length did study). A lot of of my writings are at https://www.linkedin.com/in/amgarg/depth/recent-activity/posts and I would be stoked if they get folks intrigued plenty of in a subject matter to discover in further depth. If this post experienced beneficial insights for you remark absent and/or give a like on the post and on the Tau Ventures’ LinkedIn web site, with because of thanks for supporting our do the job. All viewpoints expressed here are my own.